Analysts have raised their price target for SBI Life Insurance slightly, from ₹2,132.53 to ₹2,145.21. They cite minor improvements in projected profit margins and the company’s overall fair value assessment as reasons for the adjustment.
What's in the News
- The Board of Directors is scheduled to meet on October 24, 2025, at 11:30 IST to consider and approve the audited financial results for the quarter and half year ended September 30, 2025 (company filing).
- Joint statutory auditors M/s. K S Aiyar & Co and M/s. J Singh & Associates will issue audit reports with unmodified opinion for the period ending September 30, 2025 (company filing).
- M/s. J Singh & Associates have accepted appointment as Joint Statutory Auditor for the financial year 2025-2026 following approval from the Comptroller & Auditor General of India (company filing).
Valuation Changes
- Fair Value has risen slightly, from ₹2,132.53 to ₹2,145.21.
- Discount Rate remains unchanged at 12.76%.
- Revenue Growth projection is steady at 22.29%.
- Net Profit Margin has increased marginally, from 1.99% to 2.01%.
- Future P/E has decreased slightly, from 81.43x to 81.26x.
Have other thoughts on SBI Life Insurance?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.